These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13882798)

  • 1. A comparison of the hemagglutination-inhibition, neutralization and complement fixation tests in the assay of antibody to measles.
    CUTCHINS EC
    J Immunol; 1962 Jun; 88():788-95. PubMed ID: 13882798
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of measles neutralizing and hemagglutination-inhibition antibody titers in individual sera.
    Fulginiti VA; Kempe CH
    Am J Epidemiol; 1965 Sep; 82(2):135-42. PubMed ID: 5828888
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of enzyme-linked immunosorbent assay for acute measles with hemagglutination inhibition complement fixation, and fluorescent-antibody methods.
    Kleiman MB; Blackburn CK; Zimmerman SE; French ML
    J Clin Microbiol; 1981 Aug; 14(2):147-52. PubMed ID: 7024302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMPARISON OF THE HEMAGGLUTINATION INHIBITION TEST FOR MEASLES WITH SEROLOGICAL TESTS AND ITS APPLICATION TO A FIELD TRIAL.
    KUNITA N; KITAWAKI T; FUNAHASHI S; TOYOSHIMA K
    Biken J; 1963 Jul; 6():45-56. PubMed ID: 14147705
    [No Abstract]   [Full Text] [Related]  

  • 5. HEMAGGLUTINATION-INHIBITION TEST IN THE STUDY OF MEASLES IMMUNITY.
    TOGO Y
    Am J Hyg; 1964 May; 79():250-9. PubMed ID: 14159946
    [No Abstract]   [Full Text] [Related]  

  • 6. [COMPARATIVE EVOLUTION OF HEMAGGLUTINATION-INHIBITING, COMPLEMENT-FIXING AND NEUTRALIZING ANTIBODIES DURING AN EPIDEMIC DUE TO ADENOVIRUS 7A].
    HENRY M; SOHIER R; CHARDONNET Y
    Ann Inst Pasteur (Paris); 1965 Feb; 108():180-95. PubMed ID: 14308777
    [No Abstract]   [Full Text] [Related]  

  • 7. DEMONSTRATION OF HUMAN MEASLES ANTIBODY BY MIXED AGGLUTINATION.
    BARRON AL; MILGROM F; KARZON DT; WITEBSKY E
    J Immunol; 1963 Jun; 90():908-13. PubMed ID: 14050201
    [No Abstract]   [Full Text] [Related]  

  • 8. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorescent antibody and complement-fixation tests of agents isolated in tissue culture from measles patients.
    COHEN SM; GORDON I; RAPP F; MACAULAY JC; BUCKLEY SM
    Proc Soc Exp Biol Med; 1955 Oct; 90(1):118-22. PubMed ID: 13273372
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity following congenital measles.
    Dörffel W; Nöbel B
    Scand J Infect Dis; 1972; 4(2):161-3. PubMed ID: 5070510
    [No Abstract]   [Full Text] [Related]  

  • 12. Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis.
    Brown P; Cathala F; Gajdusek DC; Gibbs CJ
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):956-61. PubMed ID: 4934707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of hemagglutination-inhibiting antibodies against measles virus and mumps virus and complement-fixing antibodies against the respiratory syncytial virus in subjects of Swat (northwestern Pakistan)].
    Servino V; De Dominicis A; Assumma M
    Arch Ital Sci Med Trop Parassitol; 1968; 49(9):261-6. PubMed ID: 4305033
    [No Abstract]   [Full Text] [Related]  

  • 14. STUDIES ON IMMUNITY TO MEASLES.
    KRUGMAN S; GILES JP; FRIEDMAN H; STONE S
    J Pediatr; 1965 Mar; 66():471-88. PubMed ID: 14264306
    [No Abstract]   [Full Text] [Related]  

  • 15. An epizootic of measles in captive silvered leaf-monkeys (Presbytis cristatus) in Malaysia.
    Montrey RD; Huxsoll DL; Hildebrandt PK; Booth BW; Arimbalam S
    Lab Anim Sci; 1980 Aug; 30(4 Pt 1):694-7. PubMed ID: 7421117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles antibodies in patients with various types of measles infection.
    Thiry L; Dachy A; Lowenthal A
    Arch Gesamte Virusforsch; 1969; 28(3):278-84. PubMed ID: 5386785
    [No Abstract]   [Full Text] [Related]  

  • 18. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Measles antibodies in serum and CSF].
    Castaigne P; Cathala F; Chateau AF; Schuller E; Collomb P; Baylet R; Girard P; Dumas N
    Nouv Presse Med; 1973 Apr; 2(14):895-9. PubMed ID: 4574820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.